Publications by authors named "Imane Chaib"

Claim this Profile
A
Author Correction: BIM and mTOR expression levels predict outcome to erlotinib in EGFR-mutant non-small-cell lung cancer.
Niki Karachaliou, Jordi Codony-Servat, Cristina Teixidó, Sara Pilotto, Ana Drozdowskyj, Imane Chaib

Sci Rep· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Kisspeptins and norepinephrine regulate different G-protein-coupled receptor signaling pathways.
Rafael Rosell, María González-Cao, Masaoki Ito, Mireia Marco Jordan, José Luis Gómez-Vázquez, Imane Chaib

Transl Lung Cancer Res· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: KRAS inhibitors, approved.
Rafael Rosell, Andrés Aguilar, Carlos Pedraz, Imane Chaib

Nat Cancer· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
KRAS inhibitors, approved.
Rafael Rosell, Andrés Aguilar, Carlos Pedraz, Imane Chaib

Nat Cancer· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dihydroartemisinin overcomes the resistance to osimertinib in EGFR-mutant non-small-cell lung cancer.
Xueting Cai, Jing Miao, Rongwei Sun, Sainan Wang, Miguel Angel Molina-Vila, Imane Chaib

Pharmacol Res· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BRCA1 Expression and Outcome in Patients With -Mutant NSCLC Treated With Gefitinib Alone or in Combination With Olaparib.
Niki Karachaliou, Oscar Arrieta, Ana Giménez-Capitán, Erika Aldeguer, Ana Drozdowskyj, Imane Chaib

JTO Clin Res Rep· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting MET amplification in EGFR-mutant non-small-cell lung cancer.
Rafael Rosell, Imane Chaib, Mariacarmela Santarpia

Lancet Respir Med· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Src-Homology 2 Domain-Containing Phosphatase 2 in Resected Mutation-Positive Lung Adenocarcinoma.
Masaoki Ito, Jordi Codony-Servat, Ana Giménez-Capitán, Mireia Serra-Mitjans, Francisco Pérez-Ochoa, Imane Chaib

JTO Clin Res Rep· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SRC and PIM1 as potential co-targets to overcome resistance in MET deregulated non-small cell lung cancer.
Ilaria Attili, Laura Bonanno, Niki Karachaliou, Jillian Wilhelmina Paulina Bracht, Jordi Berenguer, Imane Chaib

Transl Lung Cancer Res· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Commentary: Safety and feasibility of CRISPR-edited T cells in patients with refractory non-small-cell lung cancer.
Rafael Rosell, Martyna Filipska, Imane Chaib, David Lligé, Fernando Laguia

Front Oncol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-Small-Cell Lung Cancer Signaling Pathways, Metabolism, and PD-1/PD-L1 Antibodies.
Mariacarmela Santarpia, Andrés Aguilar, Imane Chaib, Andrés Felipe Cardona, Sara Fancelli

Cancers (Basel)· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Concomitant genomic alterations in KRAS mutant advanced lung adenocarcinoma.
Joan Gibert, Sergi Clavé, Max Hardy-Werbin, Álvaro Taus, Pedro Rocha, Imane Chaib

Lung Cancer· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Osimertinib and dihydroartemisinin: a novel drug combination targeting head and neck squamous cell carcinoma.
Imane Chaib, Xueting Cai, David Llige, Mariacarmela Santarpia, Eloisa Jantus-Lewintre

Ann Transl Med· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterising acquired resistance to erlotinib in non-small cell lung cancer patients.
Niki Karachaliou, Jordi Codony-Servat, Jillian Wilhelmina Paulina Bracht, Masaoki Ito, Martyna Filipska, Imane Chaib

Expert Rev Respir Med· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting PKCι-PAK1 signaling pathways in EGFR and KRAS mutant adenocarcinoma and lung squamous cell carcinoma.
Masaoki Ito, Carles Codony-Servat, Jordi Codony-Servat, David Lligé, Imane Chaib

Cell Commun Signal· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dacomitinib for the first-line treatment of patients with EGFR-mutated metastatic non-small cell lung cancer.
Mariacarmela Santarpia, Jessica Menis, Imane Chaib, Maria Gonzalez Cao, Rafael Rosell

Expert Rev Clin Pharmacol· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hsp90 inhibitors enhance the antitumoral effect of osimertinib in parental and osimertinib-resistant non-small cell lung cancer cell lines.
Jordi Codony-Servat, Santiago Viteri, Carles Codony-Servat, Masaoki Ito, Jillian Willhelmina Paulina Bracht, Imane Chaib

Transl Lung Cancer Res· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biological therapies in lung cancer treatment: using our immune system as an ally to defeat the malignancy.
Martyna Filipska, Carlos Pedraz-Valdunciel, Imane Chaib, Rafael Rosell

Expert Opin Biol Ther· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of PALB2 Messenger RNA Expression with Platinum-Docetaxel Efficacy in Advanced Non-Small Cell Lung Cancer.
Niki Karachaliou, Jillian Wilhelmina Paulina Bracht, Manuel Fernandez Bruno, Ana Drozdowskyj, Ana Gimenez Capitan, Imane Chaib

J Thorac Oncol· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrin-linked kinase (ILK) and src homology 2 domain-containing phosphatase 2 (SHP2): Novel targets in EGFR-mutation positive non-small cell lung cancer (NSCLC).
Niki Karachaliou, Andres Felipe Cardona, Jillian Wilhelmina Paulina Bracht, Erika Aldeguer, Ana Drozdowskyj, Imane Chaib

EBioMedicine· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Common Co-activation of AXL and CDCP1 in EGFR-mutation-positive Non-smallcell Lung Cancer Associated With Poor Prognosis.
Niki Karachaliou, Imane Chaib, Andres Felipe Cardona, Jordi Berenguer, Jillian Wilhelmina Paulina Bracht

EBioMedicine· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Co-activation of STAT3 and YES-Associated Protein 1 (YAP1) Pathway in EGFR-Mutant NSCLC.
Imane Chaib, Niki Karachaliou, Sara Pilotto, Jordi Codony Servat, Xueting Cai

J Natl Cancer Inst· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activation of signal transducer and activator of transcription 3 (STAT3) signaling in EGFR mutant non-small-cell lung cancer (NSCLC).
Carles Codony-Servat, Jordi Codony-Servat, Niki Karachaliou, Miguel Angel Molina, Imane Chaib

Oncotarget· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BIM and mTOR expression levels predict outcome to erlotinib in EGFR-mutant non-small-cell lung cancer.
Niki Karachaliou, Jordi Codony-Servat, Cristina Teixidó, Sara Pilotto, Ana Drozdowskyj, Imane Chaib

Sci Rep· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Melanoma: oncogenic drivers and the immune system.
Niki Karachaliou, Sara Pilotto, Cristina Teixidó, Santiago Viteri, María González-Cao, Imane Chaib

Ann Transl Med· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis